- Patent Title: Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity
-
Application No.: US15121273Application Date: 2015-02-20
-
Publication No.: US11040093B2Publication Date: 2021-06-22
- Inventor: Tihamer Orban , Jalahej Heyman , Nara Daubeney , Piers Daubeney
- Applicant: Tihamer Orban , Jalahej Heyman , Nara Daubeney , Piers Daubeney
- Applicant Address: GB London; GB London; GB London; GB London
- Assignee: Tihamer Orban,Jalahej Heyman,Nara Daubeney,Piers Daubeney
- Current Assignee: Tihamer Orban,Jalahej Heyman,Nara Daubeney,Piers Daubeney
- Current Assignee Address: GB London; GB London; GB London; GB London
- Agency: Womble Bond Dickinson (US) LLP
- Priority: GB1403258 20140225
- International Application: PCT/GB2015/050493 WO 20150220
- International Announcement: WO2015/128617 WO 20150903
- Main IPC: A61K38/28
- IPC: A61K38/28 ; A61K39/00 ; C07K14/62 ; C07K14/47 ; G01N33/68 ; A61K45/06 ; C07K14/00
Abstract:
A composition for treating type 1 diabetes mellitus autoimmunity can include a therapeutically effective amount of two or more overlapping fragments of preproinsulin and a pharmaceutically acceptable carrier, wherein at least one of the polypeptide fragments is antigenic.
Public/Granted literature
- US20160361397A1 IMMUNOMODULATORY THERAPY FOR TYPE 1 DIABETES MELLITUS AUTOIMMUNITY Public/Granted day:2016-12-15
Information query
IPC分类:
